Login / Signup

Human menstrual blood-derived stem cells mitigate bleomycin-induced pulmonary fibrosis through anti-apoptosis and anti-inflammatory effects.

Xin ChenYi WuYanling WangLijun ChenWendi ZhengSining ZhouHuikang XuYifei LiLi YuanCharlie Xiang
Published in: Stem cell research & therapy (2020)
Collectively, our results suggested MenSCs have a great potential in the treatment of pulmonary fibrosis, and cytokines revealed in antibody array are expected to become the target of future therapy of MenSCs in clinical treatment of pulmonary fibrosis.
Keyphrases
  • pulmonary fibrosis
  • stem cells
  • endothelial cells
  • oxidative stress
  • cell death
  • high glucose
  • mesenchymal stem cells
  • mass spectrometry
  • bone marrow
  • climate change
  • combination therapy
  • cell cycle arrest